Quantcast

Latest autoimmune diseases Stories

2014-08-14 12:28:37

Expert from the Largest Scleroderma Specialty Center in the U.S. at Johns Hopkins will Provide Insight to Help Patients, Physicians and Caregivers. SAN FRANCISCO, Aug. 14, 2014 /PRNewswire-USNewswire/ -- Dr. Francisco Boin of the Scleroderma Center at The Johns Hopkins University School of Medicine, one of the largest scleroderma specialty clinics in the world, will host a live, free webinar on Thursday, August 21, 2014 at 1:00 p.m. EDT. The webinar is presented by the Scleroderma...

2014-08-14 04:21:51

CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel, Aug. 14, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP"), announced today its operating results for the quarter ended June 30, 2014. Dr. Daniel Teper, Chief Executive Officer of Immune Pharmaceuticals, Inc., stated: "Following the completion of a $10.2 million capital raise in March 2014, in the second quarter, we have been able to advance the preparation of Phase II clinical trials...

parasitic worms
2014-08-12 03:00:09

Monash University Experts believe a molecule in parasitic worms could help explain why worm infections can effectively treat a range of autoimmune diseases, including multiple sclerosis, psoriasis, rheumatoid arthritis and lupus. The Monash University study, published in the FASEB Journal, successfully identified peptides from parasitic worms that suppress the body’s immune response. Researchers believe this could pave the way for a new drug containing the peptide to provide relief...

2014-08-12 11:10:06

Wiley Readmissions more likely in black and Hispanic systemic lupus erythematosus patients A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged. Results published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), show that black and Hispanic SLE patients were more likely to be readmitted than white patients. Readmissions among patients insured by...

2014-08-12 08:31:26

Study Aims To Enroll 10,000 Individuals With Inflammatory Bowel Disease MOUNTAIN VIEW, Calif., Aug. 12, 2014 /PRNewswire/ -- 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Approximately 1.4...

2014-08-08 11:12:02

AGA Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients. These data were reported in a new study1 published in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association (AGA). Thiopurines are an established treatment for...

2014-08-08 11:10:25

ETH Zurich With a new therapeutic product, researchers have managed to cure arthritis in mice for the first time. The scientists are now planning to test the efficacy of the drug in humans. Rheumatoid arthritis is a condition that causes painful inflammation of several joints in the body. The joint capsule becomes swollen, and the disease can also destroy cartilage and bone as it progresses. Rheumatoid arthritis affects 0.5% to 1% of the world’s population. Up to this point, doctors...

2014-08-07 12:28:15

Actor Ian Harding to serve as Walk Ambassador WASHINGTON, Aug. 7, 2014 /PRNewswire-USNewswire/ -- Multi-talented entertainer and television personality Nick Cannon will serve as the Grand Marshal at the Walk to End Lupus Now(TM) event in Los Angeles on Saturday, September, 20, 2014. Cannon will cut the opening ceremony ribbon and lead the more than 5,000 walkers around Exposition Park shedding light on the cruel mystery that is lupus. Cannon was diagnosed with lupus nephritis...

2014-08-06 08:30:32

BMI analysis shows high efficacy of CF101; The data supports the design of the forthcoming Phase III clinical studies PETACH TIKVA, Israel, Aug. 6, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today new data from a retrospective analysis of its autoimmune disease advanced trials that shows high efficacy of its orally...

2014-08-01 08:26:41

NEW YORK, Aug. 1, 2014 /PRNewswire/ -- Beginning on August 1, 2014, Crohn's and Colitis Awareness Month will be observed for the first time in New York State thanks to a resolution passed by the New York State legislature in June, reported the Crohn's & Colitis Foundation of America (CCFA). There are more than 1.4 million Americans living with Crohn's disease and ulcerative colitis, which are known collectively as inflammatory bowel diseases (IBD). "We applaud Governor Andrew...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'